171 related articles for article (PubMed ID: 38197430)
1. Novel two-tiered screening approach identifies synergistic combinations of natural compounds for prostate cancer prevention and treatment.
Friedman CA; Saha A; Lavender Hackman G; Lu X; Lodi A; Tiziani S; DiGiovanni J
Mol Carcinog; 2024 Apr; 63(4):589-600. PubMed ID: 38197430
[TBL] [Abstract][Full Text] [Related]
2. Combinatorial treatment with natural compounds in prostate cancer inhibits prostate tumor growth and leads to key modulations of cancer cell metabolism.
Lodi A; Saha A; Lu X; Wang B; Sentandreu E; Collins M; Kolonin MG; DiGiovanni J; Tiziani S
NPJ Precis Oncol; 2017; 1():. PubMed ID: 29202102
[TBL] [Abstract][Full Text] [Related]
3. Prostate cancer chemoprevention by silibinin: bench to bedside.
Singh RP; Agarwal R
Mol Carcinog; 2006 Jun; 45(6):436-42. PubMed ID: 16637061
[TBL] [Abstract][Full Text] [Related]
4. Anti-cancer potential of synergistic phytochemical combinations is influenced by the genetic profile of prostate cancer cell lines.
Gano CA; Fatima S; Failes TW; Arndt GM; Sajinovic M; Mahns D; Saedisomeolia A; Coorssen JR; Bucci J; de Souza P; Vafaee F; Scott KF
Front Nutr; 2023; 10():1119274. PubMed ID: 36960209
[TBL] [Abstract][Full Text] [Related]
5. Molecular targets for green tea in prostate cancer prevention.
Adhami VM; Ahmad N; Mukhtar H
J Nutr; 2003 Jul; 133(7 Suppl):2417S-2424S. PubMed ID: 12840218
[TBL] [Abstract][Full Text] [Related]
6. A cancer chemopreventive agent silibinin, targets mitogenic and survival signaling in prostate cancer.
Singh RP; Agarwal R
Mutat Res; 2004 Nov; 555(1-2):21-32. PubMed ID: 15476849
[TBL] [Abstract][Full Text] [Related]
7. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
8. Bioactive natural products for chemoprevention and treatment of castration-resistant prostate cancer.
Kallifatidis G; Hoy JJ; Lokeshwar BL
Semin Cancer Biol; 2016 Oct; 40-41():160-169. PubMed ID: 27370570
[TBL] [Abstract][Full Text] [Related]
9. Acetyl-L-Carnitine downregulates invasion (CXCR4/CXCL12, MMP-9) and angiogenesis (VEGF, CXCL8) pathways in prostate cancer cells: rationale for prevention and interception strategies.
Baci D; Bruno A; Cascini C; Gallazzi M; Mortara L; Sessa F; Pelosi G; Albini A; Noonan DM
J Exp Clin Cancer Res; 2019 Nov; 38(1):464. PubMed ID: 31718684
[TBL] [Abstract][Full Text] [Related]
10. The strategies to control prostate cancer by chemoprevention approaches.
Ting H; Deep G; Agarwal C; Agarwal R
Mutat Res; 2014 Feb; 760():1-15. PubMed ID: 24389535
[TBL] [Abstract][Full Text] [Related]
11. Silibinin prevents prostate cancer cell-mediated differentiation of naïve fibroblasts into cancer-associated fibroblast phenotype by targeting TGF β2.
Ting HJ; Deep G; Jain AK; Cimic A; Sirintrapun J; Romero LM; Cramer SD; Agarwal C; Agarwal R
Mol Carcinog; 2015 Sep; 54(9):730-41. PubMed ID: 24615813
[TBL] [Abstract][Full Text] [Related]
12. Natural Compounds in Prostate Cancer Prevention and Treatment: Mechanisms of Action and Molecular Targets.
Fontana F; Raimondi M; Marzagalli M; Di Domizio A; Limonta P
Cells; 2020 Feb; 9(2):. PubMed ID: 32085497
[TBL] [Abstract][Full Text] [Related]
13. Silibinin inhibits hypoxia-induced HIF-1α-mediated signaling, angiogenesis and lipogenesis in prostate cancer cells: In vitro evidence and in vivo functional imaging and metabolomics.
Deep G; Kumar R; Nambiar DK; Jain AK; Ramteke AM; Serkova NJ; Agarwal C; Agarwal R
Mol Carcinog; 2017 Mar; 56(3):833-848. PubMed ID: 27533043
[TBL] [Abstract][Full Text] [Related]
14. Antiproliferative and apoptotic effects of silibinin in rat prostate cancer cells.
Tyagi A; Bhatia N; Condon MS; Bosland MC; Agarwal C; Agarwal R
Prostate; 2002 Nov; 53(3):211-7. PubMed ID: 12386921
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of action of novel agents for prostate cancer chemoprevention.
Singh RP; Agarwal R
Endocr Relat Cancer; 2006 Sep; 13(3):751-78. PubMed ID: 16954429
[TBL] [Abstract][Full Text] [Related]
16. The efficacy of natural bioactive compounds against prostate cancer: Molecular targets and synergistic activities.
Mia MAR; Dey D; Sakib MR; Biswas MY; Prottay AAS; Paul N; Rimti FH; Abdullah Y; Biswas P; Iftehimul M; Paul P; Sarkar C; El-Nashar HAS; El-Shazly M; Islam MT
Phytother Res; 2023 Dec; 37(12):5724-5754. PubMed ID: 37786304
[TBL] [Abstract][Full Text] [Related]
17. Prostate cancer prevention by silibinin.
Singh RP; Agarwal R
Curr Cancer Drug Targets; 2004 Feb; 4(1):1-11. PubMed ID: 14965263
[TBL] [Abstract][Full Text] [Related]
18. Metformin targets c-MYC oncogene to prevent prostate cancer.
Akinyeke T; Matsumura S; Wang X; Wu Y; Schalfer ED; Saxena A; Yan W; Logan SK; Li X
Carcinogenesis; 2013 Dec; 34(12):2823-32. PubMed ID: 24130167
[TBL] [Abstract][Full Text] [Related]
19. 6-Shogaol from dried ginger inhibits growth of prostate cancer cells both in vitro and in vivo through inhibition of STAT3 and NF-κB signaling.
Saha A; Blando J; Silver E; Beltran L; Sessler J; DiGiovanni J
Cancer Prev Res (Phila); 2014 Jun; 7(6):627-38. PubMed ID: 24691500
[TBL] [Abstract][Full Text] [Related]
20. Combinations of indole-3-carbinol and silibinin suppress inflammation-driven mouse lung tumorigenesis by modulating critical cell cycle regulators.
Song JM; Qian X; Molla K; Teferi F; Upadhyaya P; O Sullivan G; Luo X; Kassie F
Carcinogenesis; 2015 Jun; 36(6):666-75. PubMed ID: 25896445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
